G. Rosiello

发表

Differences in short-term outcomes between open versus robot-assisted radical cystectomy in frail malnourished patients.

F. Saad, A. Briganti, S. Shariat, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The effect of age on cancer-specific mortality in patients with prostate cancer: a population-based study across all stages

F. Saad, M. Graefen, S. Shariat, 2020, Cancer Causes & Control.

Development and Validation of the Metric-Based Assessment of a Robotic Dissection Task on an Avian Model

A. Gallagher, A. Mottrie, E. Mazzone, 2022, Journal of Surgical Research.

Development and validation of the metric-based assessment of a robotic vessel dissection, vessel loop positioning, clip applying and bipolar coagulation task on an avian model

A. Gallagher, A. Mottrie, E. Mazzone, 2021, Journal of Robotic Surgery.

The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy

U. Capitanio, F. Montorsi, A. Salonia, 2022, European Journal of Surgical Oncology.

Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy

F. Saad, F. Montorsi, N. Fossati, 2020, Prostate Cancer and Prostatic Diseases.

Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy worse radical cystectomy outcomes in frails.

F. Saad, A. Briganti, S. Shariat, 2020, Surgical oncology.

Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients.

F. Saad, A. Briganti, S. Shariat, 2020, Journal of geriatric oncology.

Clinical, surgical, pathological and follow-up features of kidney cancer patients with Von Hippel-Lindau syndrome: novel insights from a large consortium

U. Capitanio, F. Montorsi, A. Salonia, 2021, World Journal of Urology.

Technical Refinements in Superextended Robot-assisted Radical Prostatectomy for Locally Advanced Prostate Cancer Patients at Multiparametric Magnetic Resonance Imaging.

A. Larcher, I. Andras, A. Mottrie, 2020, European urology.

Small Renal Masses With Tumor Size 0 to 2 cm: A SEER-Based Study and Validation of NCCN Guidelines.

F. Saad, A. Briganti, S. Shariat, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

Survival and Complication Rates of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma Treated Exclusively With Targeted Therapy: A Combined Population-based Analysis

F. Saad, A. Briganti, S. Shariat, 2019, AntiCancer Research.

Metabolic syndrome predicts worse perioperative outcomes in patients treated with partial nephrectomy for renal cell carcinoma.

F. Saad, A. Briganti, S. Shariat, 2020, Urology.

Focal therapy for prostate cancer: what is really needed to move from investigational to valid therapeutic alternative?—a narrative review

F. Montorsi, G. Gandaglia, A. Briganti, 2021, Annals of translational medicine.

Prostate Cancer Grade and Stage Misclassification in Active Surveillance Candidates: Black Versus White Patients.

F. Saad, M. Graefen, S. Shariat, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis.

F. Saad, F. Montorsi, G. Gandaglia, 2020, Urologic oncology.

Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study

F. Saad, F. Montorsi, N. Fossati, 2020, World Journal of Urology.

Survival of Contemporary Patients With Non-metastatic Small-cell Carcinoma of Urinary Bladder, According to Alternative Treatment Modalities.

F. Saad, A. Briganti, S. Shariat, 2019, Clinical genitourinary cancer.

Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion.

F. Saad, F. Montorsi, G. Gandaglia, 2019, Clinical genitourinary cancer.

Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection.

F. Montorsi, N. Fossati, G. Gandaglia, 2021, European urology focus.

The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery

U. Capitanio, F. Montorsi, A. Salonia, 2020, World Journal of Urology.

Prognostic effect of preoperative serum albumin to globulin ratio in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma

V. Margulis, S. Shariat, P. Karakiewicz, 2021, Translational andrology and urology.

Metabolic syndrome predicts worse perioperative outcomes in patients treated with radical prostatectomy for non-metastatic prostate cancer.

F. Saad, A. Briganti, S. Shariat, 2021, Surgical oncology.

Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial.

U. Capitanio, F. Montorsi, A. Salonia, 2022, European urology focus.

Rates of other‐cause mortality after radical cystectomy are decreasing over time—A population‐based analysis over two decades

F. Saad, F. Montorsi, G. Gandaglia, 2020, Journal of surgical oncology.

The Impact of Previous Prostate Surgery on Surgical Outcomes for Patients Treated with Robot-assisted Radical Cystectomy for Bladder Cancer.

F. Montorsi, R. Schiavina*, P. Carpentier, 2021, European urology.

Contemporary rates and predictors of open conversion during minimally invasive radical prostatectomy for non-metastatic prostate cancer.

F. Saad, A. Briganti, S. Shariat, 2020, Journal of endourology.

Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression

U. Capitanio, F. Montorsi, A. Salonia, 2022, World Journal of Urology.

Salvage pelvic lymph node dissection for lymph node recurrent prostate cancer.

A. Briganti, M. Bandini, G. Rosiello, 2019, Current opinion in urology.

How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most?

U. Capitanio, F. Montorsi, A. Salonia, 2022, World Journal of Urology.

The key role of levator ani thickness for early urinary continence recovery in patients undergoing robot‐assisted radical prostatectomy: A multi‐institutional study

F. Montorsi, A. Salonia, A. Briganti, 2021, Neurourology and urodynamics.

Development and Validation of the Metric-Based Assessment of a Robotic Dissection Task on an Avian Model.

A. Gallagher, A. Mottrie, M. Amato, 2021, The Journal of surgical research.

Re: Sarah P. Psutka, Roman Gulati, Michael A.S. Jewett, et al. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.002

U. Capitanio, F. Montorsi, A. Larcher, 2022, European urology.

Does quality assured eLearning provide adequate preparation for robotic surgical skills; a prospective, randomized and multi-center study

A. Gallagher, F. Migliorini, P. Kiely, 2021, International Journal of Computer Assisted Radiology and Surgery.

A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy--A large, retrospective, single-center study.

U. Capitanio, F. Montorsi, A. Salonia, 2022, Urologic oncology.

Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines.

U. Capitanio, F. Montorsi, A. Salonia, 2020, European urology.

Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma.

U. Capitanio, F. Montorsi, A. Salonia, 2022, Urologic oncology.

Bilateral kidney metastases from adenoid cystic carcinoma of lung: a case report and literature review

R. Schiavina*, E. Brunocilla, A. Mottrie, 2021, CEN Case Reports.

Assessing pentafecta achievement after robot-assisted radical cystectomy and its association with surgical experience: Results from a high-volume institution.

R. Schiavina*, A. Mottrie, C. Bravi, 2022, Urologic oncology.

Long-term oncologic outcomes of robot-assisted radical cystectomy: update series from a high-volume robotic center beyond 10 years of follow-up

F. Montorsi, A. Briganti, M. Moschini, 2022, Journal of Robotic Surgery.

Clinical Case Debate: Immunotherapy Versus Alternative Therapies in the Neoadjuvant and Adjuvant Setting of Localized, High-Risk Prostate Cancer

N. Fossati, G. Gandaglia, A. Briganti, 2022, Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers.

Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years.

F. Saad, A. Briganti, S. Shariat, 2020, Cancer epidemiology.

How to improve outcome in nephron-sparing surgery: the impact of new techniques

U. Capitanio, F. Montorsi, A. Larcher, 2021, Current opinion in urology.

Renal Cell Carcinoma: Comparison Between Variant Histology and Clear Cell Carcinoma Across all Stages and Treatment Modalities.

F. Saad, S. Shariat, P. Karakiewicz, 2020, The Journal of urology.

Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma.

F. Saad, U. Capitanio, F. Montorsi, 2020, Urologic oncology.

The impact of sex and age on distribution of metastases in patients with renal cell carcinoma

F. Saad, U. Capitanio, F. Montorsi, 2021, International Journal of Clinical Oncology.

Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non-clear Cell Renal Cell Carcinoma Patients.

F. Saad, A. Briganti, S. Shariat, 2020, European urology focus.

The Role of miRNA in the Management of Localized and Advanced Renal Masses, a Narrative Review of the Literature

S. Parodi, V. Fasulo, L. Napolitano, 2022, Applied Sciences.

Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis

F. Saad, U. Capitanio, F. Montorsi, 2020, World Journal of Urology.

Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities

F. Saad, A. Briganti, S. Shariat, 2020, Cancer Causes & Control.

Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer.

F. Saad, F. Montorsi, A. Briganti, 2019, Urologic oncology.

Unmarried status is a barrier for access to treatment in patients with metastatic renal cell carcinoma

F. Saad, U. Capitanio, F. Montorsi, 2019, International Urology and Nephrology.

Renal cancer: overdiagnosis and overtreatment

U. Capitanio, F. Montorsi, A. Larcher, 2021, World Journal of Urology.

Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology.

F. Saad, A. Briganti, S. Shariat, 2020, European urology focus.

Case of the Month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses

U. Capitanio, F. Montorsi, A. Salonia, 2022, BJU international.

Bladder Cancer: A Comparison Between Non-urothelial Variant Histology and Urothelial Carcinoma Across All Stages and Treatment Modalities.

F. Saad, S. Shariat, P. Karakiewicz, 2020, Clinical genitourinary cancer.

Risk Factors for Intravesical Recurrence After Minimally Invasive Nephroureterctomy for Upper Tract Urothelial Cancer (Robuust Collaboration).

R. Autorino, V. Margulis, I. Derweesh, 2021, The Journal of urology.

F. Saad, F. Montorsi, A. Briganti, 2021, Japanese journal of clinical oncology.

Contemporary rates and predictors of open conversion during minimally invasive partial nephrectomy for kidney cancer.

F. Saad, A. Briganti, S. Shariat, 2020, Surgical oncology.

Simplified PADUA renal (SPARE) nephrometry score validation and long-term outcomes after robot-assisted partial nephrectomy.

U. Capitanio, F. Montorsi, A. Briganti, 2021, Urologic oncology.

Potential contenders for the leadership in robotic surgery.

A. Mottrie, K. Rha, C. Bravi, 2021, Journal of endourology.

Selective Suturing or Sutureless Technique in Robot-assisted Partial Nephrectomy: Results from a Propensity-score Matched Analysis.

F. Montorsi, A. Mottrie, E. Mazzone, 2021, European urology focus.

The IRON Study: Investigation of Robot-assisted Versus Open Nephron-sparing Surgery

K. Bensalah, U. Capitanio, F. Montorsi, 2020, European urology open science.

Prognostic factors in patients with small renal masses: a comparison between <2 vs. 2.1–4 cm renal cell carcinomas

F. Saad, U. Capitanio, F. Montorsi, 2020, Cancer Causes & Control.

Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma.

U. Capitanio, F. Montorsi, A. Salonia, 2022, Urologic oncology.

Robotic vs laparoscopic nephroureterectomy for upper tract urothelial carcinoma: a multicenter propensity-score matched pair "tetrafecta" analysis (ROBUUST collaborative group).

R. Autorino, V. Margulis, I. Derweesh, 2022, Journal of endourology.

The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder

F. Saad, S. Shariat, P. Karakiewicz, 2019, Journal of surgical oncology.

Relative Contribution of Sampling and Grading to the Quality of Prostate Biopsy: Results from a Single High-volume Institution.

F. Montorsi, A. Vickers, R. Montironi, 2020, European urology oncology.

Acute kidney injury after partial nephrectomy: transient or permanent kidney damage?-Impact on long-term renal function.

U. Capitanio, A. Larcher, G. Rosiello, 2019, Annals of translational medicine.

MP49-20 SUTURELESS TECHNIQUE IN ROBOT-ASSISTED PARTIAL NEPHRECTOMY: RESULTS FROM A PROPENSITY-SCORE MATCHED ANALYSIS

F. Montorsi, A. Mottrie, C. Bravi, 2021 .

Contemporary conditional cancer‐specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract

F. Saad, F. Montorsi, N. Fossati, 2020, Journal of surgical oncology.

F. Saad, S. Shariat, P. Karakiewicz, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution

F. Montorsi, A. Vickers, N. Fossati, 2021, Minerva Urology and Nephrology.

External beam radiation therapy improves survival in high- and intermediate-risk non-metastatic octogenarian prostate cancer patients

F. Saad, M. Graefen, A. Briganti, 2019, International Urology and Nephrology.

Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma.

V. Margulis, S. Shariat, P. Karakiewicz, 2020, Urologic oncology.

MP27-02 NOT ALL ADVERSE PATHOLOGY FEATURES ARE EQUAL: IDENTIFYING OPTIMAL CANDIDATES FOR ADJUVANT RADIOTHERAPY AMONG PATIENTS WITH ADVERSE PATHOLOGY AT RADICAL PROSTATECTOMY

U. Capitanio, F. Montorsi, N. Fossati, 2022, Journal of Urology.

Radical cystectomy improves survival in patients with stage T1 squamous cell carcinoma and neuroendocrine carcinoma of the urinary bladder.

F. Saad, S. Shariat, P. Karakiewicz, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Preoperative frailty predicts adverse short‐term postoperative outcomes in patients treated with radical nephroureterectomy

F. Saad, U. Capitanio, F. Montorsi, 2020, Journal of surgical oncology.

Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy

U. Capitanio, F. Montorsi, A. Salonia, 2022, World Journal of Urology.

Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy

F. Saad, F. Montorsi, N. Fossati, 2020, Prostate Cancer and Prostatic Diseases.

The effect of age on cancer-specific mortality in patients with prostate cancer: a population-based study across all stages

F. Saad, M. Graefen, S. Shariat, 2020, Cancer Causes & Control.

External beam radiation therapy improves survival in elderly metastatic prostate cancer patients with low PSA.

F. Saad, M. Graefen, A. Briganti, 2020, Urologic oncology.

A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer.

F. Saad, M. Graefen, A. Briganti, 2019, Clinical genitourinary cancer.

The Impact of Race and Age on Distribution of Metastases in Patients with Prostate Cancer.

F. Saad, M. Graefen, A. Briganti, 2020, The Journal of urology.

Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities

F. Saad, A. Briganti, S. Shariat, 2020, Cancer Causes and Control.

PSA, stage, grade and prostate cancer specific mortality in Asian American patients relative to Caucasians according to the United States Census Bureau race definitions

F. Saad, P. Karakiewicz, F. Chun, 2020, World Journal of Urology.

Comparison between small renal masses 0-2 cm vs. 2.1-4 cm in size: A population-based study.

F. Saad, A. Briganti, S. Shariat, 2021, Urologic oncology.

Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database-based Study.

F. Saad, A. Briganti, S. Shariat, 2020, European urology focus.

Bladder cancer incidence rates and trends in young adults aged 20-39 years.

F. Saad, A. Briganti, S. Shariat, 2020, Urologic oncology.

Effect of Age on Cancer-specific Mortality in Patients With Urothelial Carcinoma of the Urinary Bladder

F. Saad, A. Briganti, S. Shariat, 2020, American journal of clinical oncology.

Histologic Subtype, Tumor Grade, Tumor Size, and Race Can Accurately Predict the Probability of Synchronous Metastases in T2 Renal Cell Carcinoma.

F. Saad, A. Briganti, S. Shariat, 2020, Clinical genitourinary cancer.

Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma.

U. Capitanio, F. Montorsi, A. Salonia, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Partial nephrectomy in frail patients: Benefits of robot-assisted surgery.

F. Saad, U. Capitanio, F. Montorsi, 2021, Surgical oncology.

Robot-assisted Cystectomy with Intracorporeal Urinary Diversion After Pelvic Irradiation for Prostate Cancer: Technique and Results from a Single High-volume Center.

R. Schiavina*, E. Brunocilla, A. Mottrie, 2021, European urology.

Impact of the time elapsed between prostate biopsy and surgery on the accuracy of nomograms predicting lymph node invasion in patients with clinically localized prostate cancer.

F. Montorsi, A. Minervini, G. Gandaglia, 2023, Urologic oncology.

The Effect of Systemic Chemotherapy on Survival in Patients With Localized, Regional, or Metastatic Adenocarcinoma of the Urinary Bladder

F. Saad, A. Briganti, S. Shariat, 2020, American journal of clinical oncology.

Influences of Age and Comorbidities on Indication for Partial Nephrectomy: A Systematic Review

U. Capitanio, F. Montorsi, A. Salonia, 2023, Kidney Cancer.

Short Time Delay Between Previous Prostate Biopsy for Prostate Cancer Assessment and Holmium Laser Enucleation of the Prostate Correlates with Worse Perioperative Outcomes.

C. Gaudiano, R. Golfieri, R. Schiavina*, 2021, European urology focus.